Blog - Visikol - Part 29

Liver Steatosis: 2D and 3D Screening Platforms

Steatosis is characterized by abnormal retention of lipids within an organ and is most common within the liver due to [...]

Mike Johnson2021-05-28T08:08:34-05:00

Over the last few years, researchers have begun to transition from using traditional two-dimensional cell culture models for assessing [...]

Griffin Ferrara2021-05-21T08:39:40-05:00Tags: CELLINK, Visikol|

May 20th, 2021 - Today Visikol joins the CELLINK family through acquisition. The acquisition provides CELLINK the opportunity to [...]

Mike Johnson2021-05-06T14:00:23-05:00

In this episode of Digital Pathology Today, Visikol CEO Michael Johnson, PhD discusses 3D imaging in digital pathology. We [...]

At Visikol, our services have grown from our expertise in cell culture, high-content tissue imaging, and advanced digital pathology. [...]

The immune system can be broken down into two main parts: innate and adaptive responses. An innate immune response [...]

Mike Johnson2021-05-02T06:17:06-05:00Tags: NIH|

Over the last five years, Visikol has developed an extensive portfolio of advanced imaging, digital pathology and cell culture [...]

Mike Johnson2021-04-23T07:40:58-05:00

We are pleased to announce that between now and June 30th, 2021, Visikol will be accepting abstract submissions for [...]

In the last few years there has been a significant increase in the number of researchers that want to [...]

Light sheet fluorescence microscopy (LSFM) is a powerful tool in the life science researcher’s toolkit. While the old histopathology [...]